… by which the neuroendocrine macro-environment affected cervical tumor growth, invasion
and therapy resistance, while showing that miR-145 served as a target for CC therapy (36). …

… risk of cervical cancer development [78]. Furthermore, variants of major histocompatibility
complex (MHC) alleles are associated with increased risk of persistent HPV infection and …

… Therapeutic modulation of the DDR is an attractive strategy to increase treatment response
… knowledge surrounding the development of such therapies for cervical cancer in the context …

… , perturbation of antitumor immune response, alteration of gene … targets for the treatment of
cervical cancer associated with HPV … therapy strategies against cervical cancer development. …

… to carcinogenesis and tumor progression predominantly … development of cervical neoplasia.
It is now accepted that HPV may be necessary but not sufficient to cause of cervical cancer …

… of cervical patients significantly decreases as the cancer … an important role in cervical cancer
progression and metastasis. … number of deaths due to cervical cancer. Oncogenes, such …

… at Exon 21 and are responsible for several cancer progression. Osimertinib binds specifically
to this mutant site irreversibly and blocks cancer progression [86]. The identified frequent …

… HPV DNA is the only molecular marker developed for the diagnosis of cervical cancer.
Molecular abnormalities such as chromosomal anomalies, DNA mutations, cell cycle check points…

… initiation and progression of cervical cancer and discusses in … cervical cancer origin and
progression from a normal cervix … HPV infection and cervical cancer development. Post infection, …

… This is of clear importance in the context of cervical cancer, and studies with recently
developed ATR inhibitors, combined with platin-based chemoradiotherapy are eagerly awaited. …